Login | Register
Profile | Log out
logo

  • Home
  • News
  • Opinion
  • Other
    • Market Updates
    • Explainers
    • Satire
  • About
  • Contact Us
    • Contact
    • Get Covered
    • Posting Guidelines
  • Subscribe
Submit An Article

Latest Articles

  • Nanoveu Secures $2 Million to Fast-Track Commercial Launch of ECS-DoT Chip and AIoT Platform
    Nanoveu Secures $2 Million to Fast-Track Commercial Launch of ECS-DoT Chip and AIoT Platform
    • News

  • Archer Unlocks Cryogenic Sensor Breakthrough for Quantum Computing
    Archer Unlocks Cryogenic Sensor Breakthrough for Quantum Computing
    • News

  • EGL Secures $1.9M PFAS Plant Contract as Demand for Clean-Up Technologies Surges
    EGL Secures $1.9M PFAS Plant Contract as Demand for Clean-Up Technologies Surges
    • News

  • RocketDNA Secures Major Aerial Tech Contract with Vault Minerals at WA Gold Site
    RocketDNA Secures Major Aerial Tech Contract with Vault Minerals at WA Gold Site
    • News

  • BirdDog Boosts Buy-Back Offer by 40% Ahead of ASX Delisting Vote
    BirdDog Boosts Buy-Back Offer by 40% Ahead of ASX Delisting Vote
    • News

  • AML3D Launches High-Tech U.S. Facility to Power Submarine Supply Chain
    AML3D Launches High-Tech U.S. Facility to Power Submarine Supply Chain
    • News

  • Vection Enters $520K Agritech Deal to Build AI-Powered Farming Robot
    Vection Enters $520K Agritech Deal to Build AI-Powered Farming Robot
    • News

  • Unith Achieves Strong Growth in Platform Usage and Strategic Partnerships
    Unith Achieves Strong Growth in Platform Usage and Strategic Partnerships
    • News

  • FBR and Samsung Heavy Industries Execute Engineering Service Agreement for Shipbuilding Automation Project
    FBR and Samsung Heavy Industries Execute Engineering Service Agreement for Shipbuilding Automation Project
    • News

  • Bioxyne Lifts FY2025 Revenue Forecast as Psychedelics and Pharma Push Gains Pace
    Bioxyne Lifts FY2025 Revenue Forecast as Psychedelics and Pharma Push Gains Pace
    • News

Wattle Health sign 10-year agreement with Chemist Warehouse

  • In News
  • December 6, 2019
  • Bronte Moore
Wattle Health sign 10-year agreement with Chemist Warehouse

Infant product manufacturer, Wattle Health Australia Limited (ASX: WHA), are set to significantly expand their domestic and international distribution channels, following the news that the company has signed a long-term agreement with Chemist Warehouse to sell their organic range of baby products. 

The agreement would see the drugstore network which comprises of over 300 Australian stores to sell both their organic ‘Little Innocents’ skincare and ‘Uganic’ formula products, an impressive milestone for the company who only launched the formula earlier this year. Additionally, Wattle Health’s products will be made available to purchase online via Tmall, a subsidiary of Alibaba, opening up the potential for global consumers. Under the deal, Chemist Warehouse will receive equity in Wattle Health in exchange for supporting the small cap in various marketing activities. 

Wattle Health’s CEO and Co-Founder, Lazarus Karasavvidis, commented on the agreement “It’s an important addition to Wattle Health’s vertical integrated supply chain which extends from securing supply of Australian certified organic fresh milk through to a dedicated organic drying facility, and the proposed majority owned blending and packing plant all the way to the end consumer.” Chairman and Co-Founder of Chemist Warehouse, Jack Gance stated “Chemist Warehouse is committed to bringing the best brands and value to our customers. Increasingly, consumers around the world show a preference for products, particularly infant formula, that are certified organic and produced to the highest standards, especially from Australia.”

China in particular have shown a large interest in Australian manufactured infant formula over the past couple of years, following the 2008 formula scandal that saw six infants die and 300,000 ill. The increased demand in specialised formula types have seen supermarkets take extreme measures including limiting purchase quantities and locking up formula. As such, it is hardly surprising that is has been reported that the infant formula market size is anticipated to be worth over US$100B, from an estimated US$45.12B last year (Fortune Business Insights, 2019). 

The agreement between the companies is subject to Wattle Health finalising the acquisition of Blend and Pack, receiving the appropriate shareholder approval, and receiving at least A$62m, via a rights issue by the end of the year. The company has not traded since September this year following an extension of a voluntary suspension from the ASX. The company will be holding an extraordinary AGM on 16 December to seek shareholder approval for the acquisition, at which time it is expected to re-commence trading shortly after.

  • About
  • Latest Posts
Bronte Moore
Bronte Moore is a business journalist at Emerald Financial whilst also completing a JD at the University of Melbourne.
Latest posts by Bronte Moore (see all)
  • This small biotech is the definition of a quiet achiever, here’s why it might be time to tune in - November 25, 2021
  • New CEO flags 100-day plan for Crowd Media’s conversational AI platform - October 19, 2021
  • Healthia emerges as largest physiotherapy provider with $88m acquisition, more growth still to come - September 22, 2021
  •  
  •  
  •  
  •  
  • asx wha
  • baby formula
  • Chemist Warehouse
  • infant formula
  • Lazarus Karasavvidis
  • Wattle Health
  • WHA
  • News

Leave a Comment

You must be logged in to post a comment.

  • About
  • Latest Posts
Bronte Moore
Bronte Moore is a business journalist at Emerald Financial whilst also completing a JD at the University of Melbourne.
Latest posts by Bronte Moore (see all)
  • This small biotech is the definition of a quiet achiever, here’s why it might be time to tune in - November 25, 2021
  • New CEO flags 100-day plan for Crowd Media’s conversational AI platform - October 19, 2021
  • Healthia emerges as largest physiotherapy provider with $88m acquisition, more growth still to come - September 22, 2021

Login or register for free to access unlimited reading

Register Now!
  • About
  • Latest Posts
Bronte Moore
Bronte Moore is a business journalist at Emerald Financial whilst also completing a JD at the University of Melbourne.
Latest posts by Bronte Moore (see all)
  • This small biotech is the definition of a quiet achiever, here’s why it might be time to tune in - November 25, 2021
  • New CEO flags 100-day plan for Crowd Media’s conversational AI platform - October 19, 2021
  • Healthia emerges as largest physiotherapy provider with $88m acquisition, more growth still to come - September 22, 2021
  • News

  • Opinion

  • Satire

  • About

  • Contact Us

  • Subscribe

The content published on this website is solely for general information purposes and is not to be construed as financial advice. Should you seek financial advice you should consult with an appropriately qualified person. Opinions expressed on this site are subject to change without notice and The Sentiment who produced this content is under no obligation to keep the information current. The Sentiment, affiliated companies & associates may have a conflict of interest with companies discussed on the website due to commercial arrangements, for example they may be shareholders in the company, be engaged by them to assist in investor communications or receive commission/brokerage for funds raised.

Copyright © 2020 The Sentiment. All rights reserved.
Subscribe

Enter your email address below to subscribe to The Sentiment’s weekly newsletter, highlighting the top news, research, opinion and satire articles shaping ASX investor sentiment.

The Sentiment respects your privacy and will not spam you. View our privacy policy here.